title: Treatment and timing in invasive mould disease.
abstract: Invasive mould disease is a growing threat for immunocompromised patients. The optimum time to use mould-active antifungal agents is much debated. Current approaches to antifungal prophylaxis, early treatment (empirical and pre-emptive therapy) and treatment of documented mould infections in onco-haematology patients are discussed.
authors.affiliation: Department of Hematology, Acute Leukemia and Stem Cell Transplantation Unit, University Hospitals Leuven, Campus Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. johan.maertens@uz.kuleuven.ac.be
authors.forename: Johan
authors.initials: J
authors.lastname: Maertens
authors.forename: Andreas H
authors.initials: AH
authors.lastname: Groll
authors.forename: Catherine
authors.initials: C
authors.lastname: Cordonnier
authors.forename: Rafael
authors.initials: R
authors.lastname: de la Cámara
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Roilides
authors.forename: Oscar
authors.initials: O
authors.lastname: Marchetti
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage*; D018890:Chemoprevention / Q000379:methods; D006801:Humans; D016867:Immunocompromised Host; D009181:Mycoses / Q000188:drug therapy* / Q000517:prevention & control; D013997:Time Factors
chemical_list: D000935:Antifungal Agents